Thu, Apr 24, 2014, 5:18 AM EDT - U.S. Markets open in 4 hrs 12 mins


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • jrabelow1 jrabelow1 Oct 30, 2013 9:43 PM Flag

    $93 pricre target from $88

    Vertex Pharmaceuticals (NASDAQ:VRTX): Baird believes that the weakness in Vertex following third-quarter earnings is a buying opportunity, pointing to Vertex’s decision to eliminate a substantial portion of the Hep-C infrastructure. The cost-saving measure will yield a favorable impact to shareholders, and Baird is therefore raising its price target to $93 from $88. Vertex shares remain Outperform rated.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
66.92-1.38(-2.02%)Apr 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.